Amylyx Pharmaceuticals Inc (AMLX) Annual Balance Sheets

Annual · GAAP · USD millions
Access AMLX quarterly Balance Sheets →
This balance sheet overview for Amylyx Pharmaceuticals Inc spans from to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent226.65
Marketable Securities, Current SH90.33
Cash & Short-term Investments316.00
Accounts receivable0.09
Inventories0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.60
Total Current Assets323.67
Equipment/Property/Plant Net0.31
Other Assets, Noncurrent8.66
Operating Lease Right Of Use Asset5.18
Total Assets332.65
Liabilities
Accounts Payable, Current AC3.52
Accrued Liabilities, Current AC17.91
Other Liabilities, Current1.26
Total Current Liabilities22.69
Total Long-term Debt0.00
Other liabilities, Noncurrent4.70
Operating Lease Liability Current1.26
Operating Lease Liability Noncurrent4.70
Total Liabilities27.39
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,056.27
Retained Earnings / Accumulated Deficit-751.43
Other Equity0.40
Common Stockholder's Equity305.26
Total Stockholder's Equity305.26
Liabilities & Stockholder's Equity332.65
4 historic quarters locked

Sign in to unlock the full Amylyx Pharmaceuticals Inc balance sheet history.

About Amylyx Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-086645

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License